Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Like we said Dr Frost 400k
Definitely like the left.. I’m guess he bought more. This new guy said he has been friends with Dr Frost for a long time. He just got his payment for that I guess. Once they sell BRL and Dr Cohen is gone they will be turning out the lights. At least Rubin didn’t talk. Get rid of Logal. Get the fork out..
Snoozer of a CC and a 19% bounce, go figure. More form 4’s in a day or so? Who or what else is propping this up?
Go figure, Dr. Frost, the oldest person in the…..room is the last one playing. Everyone else has left the building and he is the only one left to turn the lights out when this is all said and done. Well, maybe him and a few “new” friends.
Its all about control, just like the left, clawing and grasping at whatever they can on their way out refusing to give up control.
What a bunch of degenerates running this.
What increase in revs did we just get for $300 mil?
OPKO acquired ModeX for $300 million in OPKO common stock.
Dilution
OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases
I’m guessing low $2s by eod Tuesday
Hopefully they announce the firing of Logal and Rubin.. let them join the circus as the clowns they are
Yea I know it’s not happening. Tell me what they ADD to the bottom line?
Looking at the new 10-K should make any investors blood boil. The amount of money they pay these clowns with the exception of Dr Cohen is beyond ridiculous. Everybody gets a trophy.
OPK has so much potential to be $12 to $15. $$$ stock. But management sucks. Did made good money here before .but is unbelievable. Cramer said it long time ago and he was right. And i listen to him got out on time
But now is under $3 a share . I be a buyer today I hope can start my position at $2.7s or so but i take $2.8s too . could be a good flip once again.
So much potential gone wasted here.
I don’t think cc until may. OPKO will never go anywhere.. it needs to be broken up and sold off in pieces.
Are they going to announce Q1 earnings tomorrow as projected?
Someone betting on more increases in Admin expenses to generate more losses.
Over 45 million shares now short, over 11% of shares outstanding are now sold short with over 11 days to cover at current volume.
We always seem I be on the same page as far as OPKO.. if it had the right management it could have been successful. BRL will survive and be sold in my opinion. Only thanks to Dr Cohen
Anavex (AVXL) is on track for multiple CNS indications, including Alzheimer's.
Opko doesn't' stand a chance.
Yes unfortunately biotech in general is seeing an outgoing tidal wave of support. I didnt check opk but in Avxl I noticed that in May June we went to $30 and the rest of the sector exploded as well.
Im guessing we see a inbound raising tide about the time we see our Alzheimer’s ph 3 topline data. If opko has some good news to release soon they might see a rush too but I agree, put a for in it already. Opko is one of the biggest running jokes imo.
For the first time I’m not thinking at all about buying this drop. It’s unfortunate I let myself be fooled for so long.
I believe and rest well at night knowing that those involved in alleged wrongdoings listed in the link you listed will have to repent for their sins and that donating to a museum with hour name on it does not count when you come before God himself.
http ://www.sec.gov/litigation/complaints/2018/comp-pr2018-182.pdf
“ “It is easier for a camel to pass through [the] eye of [a] needle than for one who is rich to enter the kingdom of God.” – Mark 10:25
Tred
dr your talking to a couple of longtimers here. Frost and his checkered past is all too well known unfortunately. He has a different agenda than his past business ventures and being transparent while building shareholder value is not one of them.
Good luck to you.
I agree about his purchases being pocket change. Interesting video. I thought OPKO was his encore. I have recently had a change in thinking. I am just waiting for an exit. I believe in Dr Cohen but the rest of them belong in the land of misfit toys. A lot of wasted time and money here.
Phil Frost is 86. He and his wife live in a monster house on Star Island in Miami, "owned by the largest drug dealer in south florida" ...
I think it might have been the SA article or something that will end up being nothing. 4K score mentioned on Fox Business. I don’t know why people buy because Dr Frost buys.
Or…..Phillip Frost just propping up the shareprice with his purchases yet to be revealed, again.
Where would this stock be with the incompetence of management if Frost didnt buy regularly. I think thea swer would be it would be down in penny land.
Da plane! Da plane!
Some call buying for end of this week in Pfizer. Maybe Soma approval. lol I couldn’t resist. I figured there were still a few of us bagholders left that might still make those type of ridiculous connections.
At least iAvxl’s price has been on sale, even with great PDD data just released yesterday. Absolutely amazing!
Good luck!
I have watched AVXL but won’t jump in until I get rid of this one. Good Luck with it.. I hope it does well.
Many companies were a giant waste of time these last few years. Largely due in part to the giant sucking sound of Amazon, aaple, tesla and the like asphyxiating the rest of the market. And the big three BP’s taking in multiple billions of dollars….I think they literally have my grandkids future savings account numbers. It has all been an over exuberant market built on lies, lies, and more damn lies! When does the musical chairs end?
I still like Mux when gold and silver explode and Im sticking with Avxl for my wildcat baby bio. Im hoping it becomes “insulated” from the market with in 6 months.
Good luck!
I have reached the point of just wanting an exit. A waste of time and money. Strongest market of my lifetime and I sat on way too much cash here. Terrible leadership. It’s nothing but a cash sucking party for them. They could sell this for $20share and I would consider it an epic failure.
I think I would be more worried if this didnt happen considering the history here.
Word has it Frosty will retire his personal shares when he retires or passes on from this world. (Not his trusted shares) So his personally boughten share should be looked at as a company buyback plan to be retired at a later date!! Just dreamin, but how sweet would it be if Frosty gave back to his shareholders in this way,
I don’t completely disagree. The saying “follow the money” holds true for every second of everything in our lives. I find it hard to believe there are many investment relationships over the years that are worse than the one between OPKO management and it’s shareholders. If it weren’t for Dr Cohen and unfortunately the pandemic we we would have been in the $1s at best. We need a real management team that wants to succeed not one that wants to suck the money and the life out of the company. Keep Dr Cohen and get rid of the rest.
I've been following SINT for several years. They are working on Silicon Nitride which should be superior to the titanium used in prosthetics whick is KNOWN to be toxic. They have a connection with the major manufacturer but it just goes nowhere..
Makes you seriously consider that the medical establishment just wants to keep us sick so they can make money.
I used to believe there was a wink and a nod but not so sure anymore. I think top mgt is milking the company and the shareholders for everything they can. Rayaldee was approved and they have done NOTHING with it. In the last cc they still used the pandemic as the excuse. Low vitamin D levels have been shown to cause more severe problems from Covid. We have Rayaldee and they sat on it. Even if it can only be used for CKD patients, they didn’t push for that and they are vulnerable. 4K score is just there. They hyped it and nothing. BLR was the most visible Covid tester and we have very little $ to show for it. To this point it is a manipulated EPIC failure.
Thanks for the insight, LOL!!!
Is it possible that there is a wink and a nod deal with Big Pharma for a buyout so they don't have to take the R&D risk?
Also Big Pharma will want to poison people with toxic meds as long as possible because it is avery profitable business model. If folks wake up they can change the game plan.
The CEO buys a lot and owns 30+% here. There are a lot of long term holders here expecting a billionaire like Dr Frost to sell at some point. If you enjoy banging your head against the wall you can invest here. Nobody knows where this is headed. It’s a crap shoot.
The deal hasn’t closed yet.
You better hurry because within minutes after I sell, Dr Frost will announce a sale at a huge premium lol
That's odd since it's still on the site...
Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease
Program Supports Access to A Pivotal Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency (DCA/PDCD trial; NCT02616484)
News provided by
Saol Therapeutics
Mar 01, 2022, 06:00 ET
Share this article
ROSWELL, Ga., March 1, 2022 /PRNewswire/ -- Saol Therapeutics, a company researching new treatments for rare diseases, is pleased to announce a collaboration with GeneDx, Inc. a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), to assist in identifying patients diagnosed with a rare mitochondrial disease, Pyruvate Dehydrogenase Complex Deficiency (PDCD) who may be eligible to participate in a Phase 3 clinical trial. PDCD affects less than 300 children in the United States annually and lacks any FDA-approved treatment.
This pivotal phase 3 trial administers the investigational drug dichloroacetate (DCA) to young children who have a deficiency of the pyruvate dehydrogenase complex (PDC). PDC deficiency is the most common cause of congenital lactic acidosis and is frequently a fatal metabolic disease of childhood. DCA has Orphan Product designation from the FDA for congenital lactic acidosis (CLA), including patients with PDCD.
GeneDx, in collaboration with Saol, will help make clinicians who treat PDCD aware of this pivotal trial.
GeneDx's advanced genetic testing provides diagnostic information on disease-causing genetic changes thanks to expert gene variant interpretation built on the combination of an unparalleled dataset and deep clinical knowledge. Through the program, GeneDx, in collaboration with Saol, will help make clinicians who treat PDCD aware of this pivotal trial in an effort to possibly accelerate patient recruitment among this highly targeted patient population.
Dr. Peter Stacpoole, Principal Investigator of the DCA/PDCD trial and Prof. of Medicine at the University of Florida, notes, "There are currently no FDA-approved treatments for patients with PDCD. Despite this, finding and recruiting children appropriate for participation in clinical trials is not easy. With the help of GeneDx, we hope to complete trial recruitment this year."
Dave Penake, CEO of Saol Therapeutics, is excited about the collaboration with GeneDx. "Individualized genetic screening offers physicians and families the insights needed to avoid years of misdiagnosis. With their help, we are better able to identify mitochondrial diseases early. Without this technology, recruitment for a disease like PDCD could take many years to complete."
About Saol Therapeutics
Saol Therapeutics (pronounced "Sail") is a privately held, biopharmaceutical company with operations in Roswell, GA, Dublin, Ireland and Hamilton, Bermuda. Saol is focused on clinical development activity in rare diseases, with a focus on mitochondrial disorders, as well as central nervous system disorders such as spasticity and pain management. Saol is one of the collaborators on a Phase 3 trial studying the first potential treatment for pyruvate dehydrogenase complex deficiency (PDCD). More information on the clinical trial can be found at Phase 3 PDCD Trial. More information about Saol can be found at https://saolrx.com/.
About GeneDx
GeneDx, Inc. is a global leader in genomics, providing testing to patients and their families from more than 55 countries. Originally founded by scientists from the National Institutes of Health, GeneDx offers a world-renowned clinical genomics program with particular expertise in rare and ultra-rare genetic disorders. In addition to its market-leading exome sequencing service, GeneDx offers a suite of additional genetic testing services, including diagnostic testing for hereditary cancers, cardiac, mitochondrial, neurological disorders, prenatal diagnostics, and targeted variant testing. GeneDx is a subsidiary of BioReference Laboratories, Inc., a wholly owned subsidiary of OPKO Health, Inc. To learn more, please visit https://www.genedx.com/.
SOURCE Saol Therapeutics
Selling Genedx to Sema4 (SMFR)
OPK gets $150 million and 80 million shares of SMFR
I dont think it is diagnosing anything.
I believe they wrote claros off a few qtrs back.
No problem.
However, OPK is in the process of selling this to Sema4.
Hmm... This is what I was looking for, so how does this sale affect the value of the company?
Does anyone know if this device will be diagnosing mitochondrial level dysfunction? I see this as the future of medicine...
So BlackRock and Vanguard own 5% each, 32% total institutions:
File Date Form Security Prev
Shares Current Shares Change(Percent)
Ownership (Percent) Change (Percent)
2022-02-10 13G/A VANGUARD GROUP INC 34,450,154 35,725,424 3.70 5.24 1.95
2022-02-01 13G/A BlackRock Inc. 37,716,833 34,390,912 -8.82 5.00 -10.71
I was looking for a company that was working on this...
Thanks for posting it...
https://mma.prnewswire.com/media/1631016/GeneDx_logo.jpg
Followers
|
257
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
15799
|
Created
|
08/17/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |